Professionals and Partners
Go to Professionals and Partners

Professionals and Partners

Our core expertise is the development and manufacturing of high-quality generic and in-licensed medicines with a proven cost-effectiveness ratio.

Individuals and Families
Go to Individuals and Families

Individuals and Families

We believe in improving the life of individuals and families by using the best current research. We use our resources to drive future scientific and manufacturing development for the constant betterment of therapies.

Home

Tchaikapharma High Quality Medicines Inc. is devoted to providing individuals and families with a wide range of affordable contemporary high-quality pharmaceuticals fighting socially significant diseases.

  • November 16, 2023

    The latest medicinal product to receive Marketing Authorisation from the Bulgarian Drug Agency is:   Ferbessa 4 mg/5 mg tablets   Ferbessa 8 mg/5 mg tablets   Ferbessa is a combination of the two active substances: perindopril and amlodipine. Perindopril is an angiotensin-converting enzyme inhibitor (ACE inhibitor). Amlodipine is a calcium antagonist that belongs to […]

  • October 2, 2023

    mag. pharma. Silvia Patrikova, Director of ‘Pharmaceutical Care’ and Member of the Board of Directors of Tchaikapharma High Quality Medicines   Nearly two years after the peak of the COVID-19 pandemic, the global pharmaceutical market is suffering from chaos in supply chains and unpredictable dynamics in demand for individual products. It is difficult to guarantee […]

  • July 14, 2023

    For 22 years at Tchaikapharma I have learned a lot – the key to success is to climb all the “steps” consistently – says Mgr. Pharm. Silvia Patrikova, member of the Board of Directors of Tchaikapharma   Ms. Patrikova, how would you introduce yourself in three sentences?   I graduated in Pharmacy at MU-Sofia and […]

  • July 3, 2023

    “Tchaikapharma is the first Bulgarian organization to support the Stand Up To Cancer initiative. What was your motivation and why now?   SU2C is massively supported by the entertainment industry and leading global media with a very critical and self-critical view on the funding and implementation of scientific programs and research. With one important exception […]

  • May 15, 2023

    The second scientific conference “Fundamentals of Cardiovascular Pharmacotherapy – Combination Therapy” was held in Sofia between May 12-14, 2023 on the initiative of the Academy-Cardiology Foundation, Logartis Foundation and Arbilis Ltd, in collaboration with the Bulgarian Society of Pharmacy and the National Association of General Practitioners in Bulgaria. As a leading manufacturer of combination products […]